Pharmacokinetic and pharmacodynamic similarity evaluation between an insulin glargine biosimilar product and Lantus(®) in healthy subjects: Pharmacokinetic parameters of both parent insulin glargine and M1 were used as endpoints

Insulin glargine is a long-acting insulin analog, which plays an important role in the treatment of diabetes mellitus. Biosimilar products of insulin glargine can provide patients with additional safe, high-quality, and potentially cost-effective options for treating diabetes. This article presents...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yiya, Zhou, Ying, Ding, Juefang, Li, Xianjing, Guo, Fengxue, Zhang, Jianfei, Ding, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459017/
https://www.ncbi.nlm.nih.gov/pubmed/36091767
http://dx.doi.org/10.3389/fphar.2022.962201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459017/
https://www.ncbi.nlm.nih.gov/pubmed/36091767
http://dx.doi.org/10.3389/fphar.2022.962201

Ejemplares similares